FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
British Journal of Cancer, Published online: 22 August 2019; doi:10.1038/s41416-019-0553-zFXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Renata A. Tassi Angela Gambino Laura Ardighieri Eliana Bignotti Paola Todeschini Chiara Romani Laura Zanotti Mattia Bugatti Fulvio Borella Dionyssios Katsaros Germana Tognon Enrico Sartori Franco Odicino Chiara Romualdi Antonella Ravaggi Source Type: research